Yunnan Botanee Bio-Technology Group Co.LTD Stock price

Equities

300957

CNE100004G74

Personal Products

End-of-day quote Shenzhen S.E. 06:00:00 2024-02-29 pm EST 5-day change 1st Jan Change
65.43 CNY -0.20% Intraday chart for Yunnan Botanee Bio-Technology Group Co.LTD +0.97% -4.02%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Enjoy this offer
* See conditions on site
Sales 2023 * 6.16B 857M Sales 2024 * 7.72B 1.07B Capitalization 27.72B 3.85B
Net income 2023 * 1.24B 172M Net income 2024 * 1.53B 213M EV / Sales 2023 * 4.02 x
Net cash position 2023 * 2.95B 410M Net cash position 2024 * 3.74B 520M EV / Sales 2024 * 3.1 x
P/E ratio 2023 *
22.2 x
P/E ratio 2024 *
17.9 x
Employees 3,053
Yield 2023 *
1.35%
Yield 2024 *
1.62%
Free-Float 27.75%
More Fundamentals * Assessed data
Dynamic Chart
Tranche Update on Yunnan Botanee Bio-Technology Group Co.LTD's Equity Buyback Plan announced on August 30, 2023. CI
In China's slowing beauty market, big brand discounts won't cut it RE
Shanghai Weimu Medical Technology Co., Ltd. announced that it has received CNY 100 million in funding from Yunnan Botanee Bio-Technology Group Co.LTD, Huajin Avenue Investment Co., Ltd., SHAREWIN Equity Investment and Management Co., Ltd., Shanghai CS Capital Co., Ltd, Sinvo Capital Holdings Co., Ltd., Investment Arm, IDG Capital Partners Co., Ltd. CI
Jefferies Adjusts Yunnan Botanee Bio-Technology’s Price Target to 87 Yuan From 105 Yuan, Keeps at Hold MT
Yunnan Botanee Bio-Technology Group Co.LTD Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Yunnan Botanee Bio-Technology Group Co.LTD announces an Increase in Equity Buyback. CI
Weimai Medical Technology Co., Ltd. announced that it has received funding from Yunnan Botanee Bio-Technology Group Co.LTD CI
Yunnan Botanee Bio-Technology Group Co.LTD announces an Equity Buyback for CNY 200 million worth of its shares. CI
Yunnan Botanee Bio-Technology Group Co.LTD authorizes a Buyback Plan. CI
Yunnan Botanee’s H1 Profit Jumps 14% as Revenue Grows 15.5% MT
Yunnan Botanee Bio-Technology Group Co.LTD Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Shanghai Ruishi Health Technology Co., Ltd. announced that it has received CNY 100 million in funding from BRV Partners, LLC, Yaojin Private Equity Fund Management Co., Ltd., Sinovation Ventures Enterprise Management Limited, Yunnan Botanee Bio-Technology Group Co.LTD CI
Yunnan Botanee Seeks to Double Revenue in Three Years MT
Jefferies Adjusts Yunnan Botanee Bio-Technology’s Price Target to 105 Yuan From 132 Yuan, Keeps at Hold MT
Yunnan Botanee Bio-Technology Group Co.LTD Implements Final Profit Distribution Plan of A Shares for 2022, Payable on 30 May 2023 CI
More news
1 day-0.20%
1 week+0.97%
Current month-0.20%
1 month+18.10%
3 months-7.45%
6 months-37.88%
Current year-4.02%
More quotes
1 week
62.21
Extreme 62.21
66.80
1 month
51.50
Extreme 51.5
66.80
Current year
51.50
Extreme 51.5
70.50
1 year
51.50
Extreme 51.5
138.50
3 years
51.50
Extreme 51.5
289.35
5 years
51.50
Extreme 51.5
289.35
10 years
51.50
Extreme 51.5
289.35
More quotes
Managers TitleAgeSince
Chief Executive Officer 61 14-05-31
Director of Finance/CFO 42 16-11-30
Director/Board Member 45 12-06-30
Members of the board TitleAgeSince
Director/Board Member 56 13-09-30
Chief Executive Officer 61 14-05-31
Director/Board Member 42 12-12-31
More insiders
Date Price Change Volume
24-03-01 65.43 -0.20% 2,191,740
24-02-29 65.56 +4.06% 3,000,964
24-02-28 63 -2.52% 4,845,012
24-02-27 64.63 +0.98% 2,086,805
24-02-26 64 -1.23% 2,356,957

End-of-day quote Shenzhen S.E., March 29, 2024

More quotes
Yunnan Botanee Bio-Technology Group Co LTD is a Chinese company mainly engaged in the production of cosmetics. The Company adopts a sales model based on offline channel sales and online channel sales as the leading factor. The Company's products mainly include creams, skin care lotions, facial masks, essences, lotions and other skin care products and make-up products such as isolation creams, blemish balm (BB) creams, and makeup removers. The Company is also engaged in the research and development, production and sales of skin care-related medical device products, mainly including hyaluronic acid repairing biofilm, hyaluronic acid repairing dressings, mainly used for the protection of skin with damaged barriers after minimally invasive surgery and care.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
25
Last Close Price
65.43 CNY
Average target price
100.8 CNY
Spread / Average Target
+54.03%
Consensus
  1. Stock
  2. Equities
  3. Stock Yunnan Botanee Bio-Technology Group Co.LTD - Shenzhen S.E.
-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities.
SIGN UP NOW